Search All Resources
Screening for Hepatocellular Carcinoma | June 23, 2021
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcc #hepatocellular carcinoma
Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. In this presentation, Dr. Jon Gerry, surgeon and physician at Franz Liver Cancer Clinic, Providence Portland Medical ...
Date added: 06/23/21
HCV and People Who Inject Drugs | March 24, 2021
Dr. Jessica Gregg, Medical Director at DePaul Treatment Centers and lead ECHO faculty member, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder.
Date added: 03/24/21
HCV in Pregnant Women – How the Opioid Crisis is Changing the Landscape | December 8, 2020
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv and opioids #hcv and pregnancy #maternal child health #opioids #perinatal transmission #pregnancy
In this presentation, Kimberly Page, PhD, MPH, Professor of Epidemiology at The University of New Mexico, describes overall HCV infection trajectory in the US and shares trends seen in HCV infection among pregnant women and children. Kim also reviews the ...
Date added: 12/8/20
The Challenges of and Opportunities for HCV Screening and Treatment of Alaska Native persons Living in Remote Communities | November 10, 2020
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv screening #remote communities #rural communities #telemedicine
Brian McMahon, MD, Hepatologist at Alaska Native Tribal Health Consortium, shares information on the epidemiology of HCV in Alaska, explains who should be screened to detect chronic HCV infection based on recommendations from the CDC & USHSTF, discusses the barriers ...
Date added: 11/10/20
Common HCV Medication Interactions | October 13, 2020
Matthew Begay-Bruno, PharmD, Southcentral Foundation ANPCC Pharmacy, shares a valuable overview of common medication interactions with hepatitis C medications.
Date added: 10/13/20
Alcohol-Associated Liver Disease | September 8, 2020
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #alcohol-related #hepatology #liver disease
Brian McMahon, MD, Hepatologist at Alaska Native Tribal Health Consortium, shares information on alcohol-associated liver disease and new practice guidelines from AASLD focused on the diagnosis and treatment of alcohol-associated liver diseases.
Date added: 09/8/20
Barriers to Hepatitis C Care Facing People Who Use Drugs | August 11, 2020
Lauren Canary, an infectious diseases epidemiologist, shares information on the barriers to care for hepatitis C facing people who use drugs, and provides some strategies providers can use to help overcome some of these barriers.
Date added: 08/11/20
Liver Fibrosis | July 14, 2020
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #liver disease #liver fibrosis
Dr. Youssef Barbour, a Liver Specialist at the Alaska Native Medical Center shares an overview of liver fibrosis, different approaches to evaluation, as well as a some tools for calculating the level of fibrosis and how to interpret and provide ...
Date added: 07/14/20
Simplified Hepatitis C Treatment | June 9, 2020
Annette Hewitt, an ARNP with the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, provides a simplified overview of HCV treatment.
Date added: 06/9/20
HCV and People Who Inject Drugs | May 27, 2020
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #Antagonist Treatment #injection drugs #Methamphetamine Use Disorder #Mirtazapine #opioid use disorder
Dr. Jessica Gregg, Associate Professor of Medicine at OHSU, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder.
Date added: 05/27/20